Announcements Trials
Browse Landscape

Phase

Phase 2 4Phase 3 1Phase 1/2 1Phase 1 1

Status

Terminated 1

Sponsor Class

NETWORK 1

Study Type

Interventional 1

Sponsor

Cancer Type

Lymphoid 1

Conditions

Mycosis Fungoides 2Carcinoma, Non-Small-Cell Lung 2Sezary Syndrome 1Lymphoma, T-Cell, Cutaneous 1Lymphoma, Primary Cutaneous Anaplastic Large Cell 1Lymphoma 1

Interventions

liposomal amphotericin B 2Vorinostat 2Peripheral Blood Stem Cell Transplantation 2Levofloxacin 2Early Intervention, Educational 2Darbepoetin alfa 2zanolimumab 1mogamulizumab 1ferrous sulfate 1ferric gluconate 1Valacyclovir 1Ultraviolet Therapy 1Sucrose 1Radiotherapy 1Psychiatric Rehabilitation 1Pharmacogenomic Testing 1Ondansetron 1Moxifloxacin 1Morphine 1Methoxsalen 1Lenalidomide 1Ketamine 1Itraconazole 1Fluconazole 1Filgrastim 1Fentanyl 1Epoetin Alfa 1Dextromethorphan 1Cyclophosphamide 1Ciprofloxacin 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 3 × Sezary Syndrome × Bexarotene × Clear all
NCT00056056 2018-07-09

Ultraviolet Light Therapy Using Methoxsalen With or Without Bexarotene in Treating Patients With Mycosis Fungoides

European Organisation for Research and Treatment of Cancer - EORTC

Phase 3 Terminated
93 enrolled
Lymphoid

Lymphoma, Mycosis Fungoides, Sezary Syndrome

Data powered by HemOnc (CC BY 4.0) Colophon âš¡